Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of Gravidity

<b>Background</b>: Women with gestational diabetes (GDM) have an increased risk of metabolic syndrome (MS) after delivery. MS could precede gravidity. The aims of this study were (i) to detect the prevalence of MS in women at the time of GDM diagnosis, (ii) to detect the prevalence of MS...

Full description

Bibliographic Details
Main Authors: Vendula Bartáková, Katarína Chalásová, Lukáš Pácal, Veronika Ťápalová, Jan Máchal, Petr Janků, Kateřina Kaňková
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/13/5/1260
_version_ 1797264301282557952
author Vendula Bartáková
Katarína Chalásová
Lukáš Pácal
Veronika Ťápalová
Jan Máchal
Petr Janků
Kateřina Kaňková
author_facet Vendula Bartáková
Katarína Chalásová
Lukáš Pácal
Veronika Ťápalová
Jan Máchal
Petr Janků
Kateřina Kaňková
author_sort Vendula Bartáková
collection DOAJ
description <b>Background</b>: Women with gestational diabetes (GDM) have an increased risk of metabolic syndrome (MS) after delivery. MS could precede gravidity. The aims of this study were (i) to detect the prevalence of MS in women at the time of GDM diagnosis, (ii) to detect the prevalence of MS in the subgroup of GDM patients with any form of impaired glucose tolerance after delivery (PGI), and (iii) to determine whether GDM women with MS have a higher risk of peripartal adverse outcomes. <b>Methods</b><i>:</i> A cross-sectional observational study comprised <i>n</i> = 455 women with GDM. International Diabetes Federation (IDF) criteria for MS definition were modified to the pregnancy situation. <b>Results</b><i>:</i> MS was detected in 22.6% of GDM patients in those with PGI 40%. The presence of MS in GDM patients was associated with two peripartal outcomes: higher incidence of pathologic Apgar score and macrosomia (<i>p</i> = 0.01 resp. <i>p</i> = 0.0004, chi-square). <b>Conclusions</b><i>:</i> The presence of MS in GDM patients is a statistically significant risk factor (<i>p</i> = 0.04 chi-square) for PGI. A strong clinical implication of our findings might be to include MS diagnostics within GDM screening using modified MS criteria in the second trimester of pregnancy.
first_indexed 2024-04-25T00:26:43Z
format Article
id doaj.art-86e6801d419a447a941603e96bdb6509
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-04-25T00:26:43Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-86e6801d419a447a941603e96bdb65092024-03-12T16:47:45ZengMDPI AGJournal of Clinical Medicine2077-03832024-02-01135126010.3390/jcm13051260Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of GravidityVendula Bartáková0Katarína Chalásová1Lukáš Pácal2Veronika Ťápalová3Jan Máchal4Petr Janků5Kateřina Kaňková6Department of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech RepublicDepartment of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech RepublicDepartment of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech RepublicDepartment of Obstetrics and Gynaecology, University Hospital Brno, 66263 Brno, Czech RepublicDepartment of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech RepublicDepartment of Obstetrics and Gynaecology, University Hospital Brno, 66263 Brno, Czech RepublicDepartment of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic<b>Background</b>: Women with gestational diabetes (GDM) have an increased risk of metabolic syndrome (MS) after delivery. MS could precede gravidity. The aims of this study were (i) to detect the prevalence of MS in women at the time of GDM diagnosis, (ii) to detect the prevalence of MS in the subgroup of GDM patients with any form of impaired glucose tolerance after delivery (PGI), and (iii) to determine whether GDM women with MS have a higher risk of peripartal adverse outcomes. <b>Methods</b><i>:</i> A cross-sectional observational study comprised <i>n</i> = 455 women with GDM. International Diabetes Federation (IDF) criteria for MS definition were modified to the pregnancy situation. <b>Results</b><i>:</i> MS was detected in 22.6% of GDM patients in those with PGI 40%. The presence of MS in GDM patients was associated with two peripartal outcomes: higher incidence of pathologic Apgar score and macrosomia (<i>p</i> = 0.01 resp. <i>p</i> = 0.0004, chi-square). <b>Conclusions</b><i>:</i> The presence of MS in GDM patients is a statistically significant risk factor (<i>p</i> = 0.04 chi-square) for PGI. A strong clinical implication of our findings might be to include MS diagnostics within GDM screening using modified MS criteria in the second trimester of pregnancy.https://www.mdpi.com/2077-0383/13/5/1260gestational diabetes mellitusmetabolic syndromeoral glucose tolerance testpostpartum glucose intolerancepregnancy
spellingShingle Vendula Bartáková
Katarína Chalásová
Lukáš Pácal
Veronika Ťápalová
Jan Máchal
Petr Janků
Kateřina Kaňková
Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of Gravidity
Journal of Clinical Medicine
gestational diabetes mellitus
metabolic syndrome
oral glucose tolerance test
postpartum glucose intolerance
pregnancy
title Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of Gravidity
title_full Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of Gravidity
title_fullStr Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of Gravidity
title_full_unstemmed Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of Gravidity
title_short Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of Gravidity
title_sort metabolic syndrome prevalence in women with gestational diabetes mellitus in the second trimester of gravidity
topic gestational diabetes mellitus
metabolic syndrome
oral glucose tolerance test
postpartum glucose intolerance
pregnancy
url https://www.mdpi.com/2077-0383/13/5/1260
work_keys_str_mv AT vendulabartakova metabolicsyndromeprevalenceinwomenwithgestationaldiabetesmellitusinthesecondtrimesterofgravidity
AT katarinachalasova metabolicsyndromeprevalenceinwomenwithgestationaldiabetesmellitusinthesecondtrimesterofgravidity
AT lukaspacal metabolicsyndromeprevalenceinwomenwithgestationaldiabetesmellitusinthesecondtrimesterofgravidity
AT veronikatapalova metabolicsyndromeprevalenceinwomenwithgestationaldiabetesmellitusinthesecondtrimesterofgravidity
AT janmachal metabolicsyndromeprevalenceinwomenwithgestationaldiabetesmellitusinthesecondtrimesterofgravidity
AT petrjanku metabolicsyndromeprevalenceinwomenwithgestationaldiabetesmellitusinthesecondtrimesterofgravidity
AT katerinakankova metabolicsyndromeprevalenceinwomenwithgestationaldiabetesmellitusinthesecondtrimesterofgravidity